Skip to Content

GSK PLC ADR GSK

Morningstar Rating
$44.98 +0.10 (0.22%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

GSK is trading at a 23% premium.
Price
$44.98
Fair Value
$42.00
Uncertainty
Medium
1-Star Price
$23.30
5-Star Price
$38.50
Economic Moat
Hznb
Capital Allocation
Lxywyks

Bulls Say, Bears Say

Bulls

GSK's next-generation respiratory drugs and HIV drugs look poised for strong growth over the next three years.

Bears

HIV patent pressure to GSK's key drugs will likely begin in 2027, setting up a major hurdle for growth later in the decade.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GSK is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$44.88
Day Range
$44.7445.09
52-Week Range
$33.3345.93
Bid/Ask
$44.99 / $45.02
Market Cap
$91.71 Bil
Volume/Avg
750 / 3.2 Mil

Key Statistics

Price/Earnings (Normalized)
11.10
Price/Sales
2.40
Dividend Yield (Trailing)
3.30%
Dividend Yield (Forward)
3.35%
Total Yield
3.30%

Company Profile

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Core
Total Number of Employees
70,200

Competitors

Valuation

Metric
GSK
MRK
PFE
Price/Earnings (Normalized)
11.1060.4519.80
Price/Book Value
5.258.231.74
Price/Sales
2.405.442.91
Price/Cash Flow
10.8519.1318.68
Price/Earnings
GSK
MRK
PFE

Financial Strength

Metric
GSK
MRK
PFE
Quick Ratio
0.570.680.58
Current Ratio
0.871.250.91
Interest Coverage
8.943.970.74
Quick Ratio
GSK
MRK
PFE

Profitability

Metric
GSK
MRK
PFE
Return on Assets (Normalized)
11.25%5.22%4.98%
Return on Equity (Normalized)
51.21%13.56%10.90%
Return on Invested Capital (Normalized)
22.40%8.29%7.28%
Return on Assets
GSK
MRK
PFE
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
LLY
Eli Lilly and CoVtqdjklcFjqmy$732.9 Bil
JNJ
Johnson & JohnsonNnsyxddFjd$372.2 Bil
MRK
Merck & Co IncDwwmphhKgxm$332.3 Bil
ABBV
AbbVie IncBvzcmsqlcTxcw$290.2 Bil
AZN
AstraZeneca PLC ADRXpmhlrtdcYshwv$237.9 Bil
RHHBY
Roche Holding AG ADRZtvhfggwFnq$211.1 Bil
NVS
Novartis AG ADRRgcmmyrcQyzm$210.2 Bil
AMGN
Amgen IncCdryygcdlCcdc$167.6 Bil
PFE
Pfizer IncCkjdqfgtSjwj$162.3 Bil
SNY
Sanofi SA ADRDfvcvzdbdLdr$121.1 Bil

Sponsor Center